Abstract
Oncogenes encoded by human tumor viruses play integral roles in the viral conquest of the host cell by subverting crucial and relatively non-redundant regulatory circuits that regulate cellular proliferation, differentiation, apoptosis and life span. Human tumor virus oncoproteins can also disrupt pathways that are necessary for the maintenance of the integrity of host cellular genome. Some viral oncoproteins act as powerful mutator genes and their expression dramatically increases the incidence of host cell mutations with every round of cell division. Others subvert cellular safeguard mechanisms intended to eliminate cells that have acquired abnormalities that interfere with normal cell division. Viruses that encode such activities can contribute to initiation as well as progression of human cancers.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
References
Weinberg RA (1997) The cat and mouse games that genes, viruses, and cells play. Cell 88: 573–575
zur Hausen H (2001) Proliferation-inducing viruses in non-permissive systems as possible causes of human cancers. Lancet 357: 381–384
zur Hausen H (2001) Oncogenic DNA viruses. Oncogene 20: 7820–7823
Nevins JR (2001) Cell Transformation by Viruses. In: DM Knipe, PM Howley (eds): Fields Virology. Lippincott-Williams and Wikins, Philadelphia, 245–283
Parada LF, Tabin CJ, Shih C, Weinberg RA (1982) Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297: 474–478
Howley PM, Lowy DR (2001) Papillomaviruses and their replication. In: DM Knipe, PM Howley (eds): Fields Virology. Lippincott Williams and Wilkins, Philadelphia, 2197–2229
de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324: 17–27
zur Hyausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342–350
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709–720
Crum CP, McLachlin CM, Tate JE, Mutter GL (1997) Pathobiology of vulvar squamous neoplasia. Curr Opin Obstet Gynecol 9: 63–69
Klencke BJ, Palefsky JM (2003) Anal cancer: an HIV-associated cancer. Hematol Oncol Clin North Am 17: 859–872
Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347: 1645–1651
Frazer IH (2004) Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol 4: 46–54
Dyson N, Howley PM, Münger K, Harlow E (1989) The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934–937
Werness BA, Levine AJ, Howley PM (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76–79
Klingelhutz AJ, Foster SA, McDougall JK (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380: 79–82
Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157: 218–226
Lowy DR, Howley PM (2001) Papillomaviruses. In: DM Knipe, PM Howley (eds): Fields Virology Lippincott Williams and Wilkins, Philadelphia, 2231–2264
Thorland EC, Myers SL, Gostout BS, Smith DI (2003) Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 22: 1225–1237
Wentzensen N, Vinokurova S, von Knebel Doeberitz M (2004) Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 64: 3878–3884
Jeon S, Allen-Hoffmann BL, Lambert PF (1995) Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69: 2989–2997
Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, Grace M, Huh KW (2004) Mechanisms of human papillomavirus-induced oncogensis. J Virol 78: 11451–11460
Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT (1989) HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8: 3905–3910
Münger K, Phelps WC, Bubb V, Howley PM, Schlegel R (1989) The E6 and E7 genes of the human papillomavirus type 16_together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417–4421
McCance DJ, Kopan R, Fuchs E, Laimins LA (1988) Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA 85: 7169–7173
Arbeit JM, Howley PM, Hanahan D (1996) Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci USA 93: 2930–2935
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57–70
Klausner RD (2002) The fabric of cancer cell biology-Weaving together the strands. Cancer Cell 1: 3–10
Cahill DP, Kinzler KW, Vogelstein B, Lengauer C (1999) Genetic instability and darwinian selection in tumours. Trends Cell Biol 9: M57–M60
Hahn WC, Weinberg RA (2002) Rules for making human tumor cells. N Engl J Med 347: 1593–1603
Zimonjic D, Brooks MW, Popescu N, Weinberg RA, Hahn WC (2001) Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res 61: 8838–8844
Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih Ie M, Vogelstein B, Lengauer C (2002) The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 99: 16226–16231
Kinzler KW, Vogelstein B (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386: 761, 763
Loeb LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51: 3075–3079
Tomlinson IP, Novelli MR, Bodmer WF (1996) The mutation rate and cancer. Proc Natl Acad Sci USA 93: 14800–14803
Duensing S, Munger K (2003) Centrosomes, genomic instability, and cervical carcinogenesis. Crit Rev Eukaryot Gene Expr 13: 9–23
White AE, Livanos EM, Tlsty TD (1994) Differential Disruption of Genomic Integrity and Cell Cycle Regulation in Normal Human Fibroblasts by the HPV Oncoproteins. Genes and Develop 8: 666–677
Duensing S, Munger K (2004) Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 109: 157–162
Southern SA, Evans MF, Herrington CS (1997) Basal cell tetrasomy in low-grade cervical squamous intraepithelial lesions infected with high-risk human papillomaviruses. Cancer Res 57: 4210–4213
Giannoudis A, Evans MF, Southern SA, Herrington CS (2000) Basal keratinocyte tetrasomy in low-grade squamous intra-epithelial lesions of the cervix is restricted to high and intermediate risk HPV infection but is not type-specific. Br J Cancer 82: 424–428
Southern SA, Noya F, Meyers C, Broker TR, Chow LT, Herrington CS (2001) Tetrasomy is induced by human papillomavirus type 18 E7 gene expression in keratinocyte raft cultures. Cancer Res 61: 4858–4863
Southern SA, Lewis MH, Herrington CS (2004) Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation. Br J Cancer 90: 1949–1954
Meraldi P, Honda R, Nigg EA (2002) Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53(-/-) cells. Embo J 21: 483–492
Storchova Z, Pellman D (2004) From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5: 45–54
Winkler B, Crum CP, Fujii T, Ferenczy A, Boon M, Braun L, Lancaster WD, Richart RM (1984) Koilocytotic lesions of the cervix. The relationship of mitotic abnormalities to the presence of papillomavirus antigens and nuclear DNA content. Cancer 53: 1081–1087
Hinchcliffe EH, Sluder G (2001) “It Takes Two to Tango”: understanding how centrosome duplication is regulated throughout the cell cycle. Genes Dev 15: 1167–1181
Nigg EA (2002) Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2: 815–825
Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497–1501
Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Munger K (2000) The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 97: 10002–10007
Boveri T (1900) Zellenstudien IV. Über die Natur der Zentrosomen. G. Fischer, Jena
Boveri T (1902) Über mehrpolige Mitosen als Mittel zur Analyse des Zellkerns. Verh d phys-med Ges Würzburg NF 35: 67–90
Hansemann D (1890) Ueber asymmetrische Zelltheilung in Epithelkrebsen und deren biologische Bedeutung. Arch Pathol Anat Physiol Klin Med 119: 299–326
Boveri T (1914) Zur Frage der Entstehung Maligner Tumoren. Fischer, Jena
Skyldberg B, Fujioka K, Hellstrom AC, Sylven L, Moberger B, Auer G (2001) Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions. Mod Pathol 14: 279–284
Duensing S, Duensing A, Flores ER, Do A, Lambert PF, Munger K (2001) Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes. J Virol 75: 7712–7716
Duensing S, Duensing A, Crum CP, Munger K (2001) Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res 61: 2356–2360
Brinkley BR (2001) Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11: 18–21
Schaeffer AJ, Nguyen M, Liem A, Lee D, Montagna C, Lambert PF, Ried T, Difilippantonio MJ (2004) E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice. Cancer Res 64: 538–546
Riley RR, Duensing S, Brake T, Munger K, Lambert PF, Arbeit JM (2003) Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res 63: 4862–4871
Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R et al. (2004) Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430: 797–802
Duensing S, Munger K (2003) Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of retinoblastoma protein family members. J Virol 77: 12331–12335
Duensing S, Duensing A, Lee DC, Edwards KM, Piboonniyom S, Manuel E, Skaltsounis L, Meijer L, Munger K (2004) The cyclin-dependent kinase inhibitor indirubin-3’-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies. Oncogene 23: 8206–8215
Ortega S, Prieto I, Odajima J, Martin A, Dubus P, Sotillo R, Barbero JL, Malumbres M, Barbacid M (2003) Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet 35: 25–31
Tetsu O, McCormick F (2003) Proliferation of cancer cells despite CDK2_inhibition. Cancer Cell 3: 233–245
Duensing S, Münger K (2002) The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 62: 7075–7082
McClintock B (1940) The stability of broken ends of chromosomes in Zea mays. Genetics 26: 234–282
Hackett JA, Feldser DM, Greider CW (2001) Telomere dysfunction increases mutation rate and genomic instability. Cell 106: 275–286
Kessis TD, Connolly DC, Hedrick L, Cho KR (1996) Expression of HPV16 E6 or E7 increases integration of foreign DNA. Oncogene 13: 427–431
Iftner T, Elbel M, Schopp B, Hiller T, Loizou JI, Caldecott KW, Stubenrauch F (2002) Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. Embo J 21: 4741–4748
Thompson DA, Belinsky G, Chang TH-T, Jones DL, Schlegel R, Münger K (1997) The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints. Oncogene 15: 3025–3036
Thomas JT, Laimins LA (1998) Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J Virol 72: 1131–1137
Patel D, Incassati A, Wang N, McCance DJ (2004) Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M-phase proteins. Cancer Res 64: 1299–1306
Thierry F, Benotmane MA, Demeret C, Mori M, Teissier S, Desaintes C (2004) A genomic approach reveals a novel mitotic pathway in papillomavirus carcinogenesis. Cancer Res 64: 895–903
Tsukasaki K (2002) Genetic instability of adult T-cell leukemia/lymphoma by comparative genomic hybridization analysis. J Clin Immunol 22: 57–63
Tsukasaki K, Krebs J, Nagai K, Tomonaga M, Koeffler HP, Bartram CR, Jauch A (2001) Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. Blood 97: 3875–3881
Jin DY, Spencer F, Jeang KT (1998) Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93: 81–91
Haoudi A, Daniels RC, Wong E, Kupfer G, Semmes OJ (2003) Human T-cell leukemia virus-I tax oncoprotein functionally targets a subnuclear complex involved in cellular DNA damageresponse. J Biol Chem 278: 37736–37744
Semmes OJ, Jeang KT (1996) Localization of human T-cell leukemia virus type 1 tax to subnuclear compartments that overlap with interchromatin speckles. J Virol 70: 6347–6357
Park HU, Jeong JH, Chung JH, Brady JN (2004) Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1. Oncogene 23: 4966–4974
Jeang KT, Giam CZ, Majone F, Aboud M (2004) Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem 279: 31991–31994
Lemoine FJ, Marriott SJ (2002) Genomic instability driven by the human T-cell leukemia virus type I (HTLV-I) oncoprotein, Tax. Oncogene 21: 7230–7234
Shimura M, Onozuka Y, Yamaguchi T, Hatake K, Takaku F, Ishizaka Y (1999) Micronuclei formation with chromosome breaks and gene amplification caused by Vpr, an accessory gene of human immunodeficiency virus. Cancer Res 59: 2259–2264
Shimura M, Tanaka Y, Nakamura S, Minemoto Y, Yamashita K, Hatake K, Takaku F, Ishizaka Y (1999) Micronuclei formation and aneuploidy induced by Vpr, an accessory gene of human immunodeficiency virus type 1. Faseb J 13: 621–637
Minemoto Y, Shimura M, Ishizaka Y, Masamune Y, Yamashita K (1999) Multiple centrosome formation induced by the expression of Vpr gene of human immunodeficiency virus. Biochem Biophys Res Commun 258: 379–384
Rickinson AB, Kieff E (2001) Epstein-Barr Virus. In: DM Knipe, PM Howley (eds): Fields Virology. Lippincott Williams and Wilkins, Philadelphia, 2575–2627
Liu MT, Chen YR, Chen SC, Hu CY, Lin CS, Chang YT, Wang WB, Chen JY (2004) Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene 23: 2531–2539
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266: 1865–1869
Moore PS, Chang YE (2001) Kaposi’s Sarcoma-Associated Herpesvirus. In: DM Knipe, PM Howley (eds): Fields Virology. Lippincott Williams and Wilkins, Philadelphia, 2803–2833
Verschuren EW, Klefstrom J, Evan GI, Jones N (2002) The oncogenic potential of Kaposi’s sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2: 229–241
Verschuren EW, Hodgson JG, Gray JW, Kogan S, Jones N, Evan GI (2004) The role of p53 in suppression of KSHV cyclin-induced lymphomagenesis. Cancer Res 64: 581–589
Pan H, Zhou F, Gao SJ (2004) Kaposi’s sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells. Cancer Res 64: 4064–4068
Wu X, Avni D, Chiba T, Yan F, Zhao Q, Lin Y, Heng H, Livingston D (2004) SV40 T antigen interacts with Nbs1 to disrupt DNA replication control. Genes Dev 18: 1305–1316
Cotsiki M, Lock RL, Cheng Y, Williams GL, Zhao J, Perera D, Freire R, Entwistle A, Golemis EA, Roberts TM et al. (2004) Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1. Proc Natl Acad Sci USA 101: 947–952
Ricciardiello L, Baglioni M, Giovannini C, Pariali M, Cenacchi G, Ripalti A, Landini MP, Sawa H, Nagashima K, Frisque RJ et al. (2003) Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 63: 7256–7262
Hollinger FB, Liang TJ (2001) Hepatitis B Virus. In: DM Knipe, PM Howley (eds): Fields Virology. Lippincott Williams and Wilkins, Philadelphia, 2971–3036
Forgues M, Difilippantonio MJ, Linke SP, Ried T, Nagashima K, Feden J, Valerie K, Fukasawa K, Wang XW (2003) Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles. Mol Cell Biol 23: 5282–5292
Yun C, Cho H, Kim SJ, Lee JH, Park SY, Chan GK (2004) Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-activated protein/extracellular signal-regulated kinase-mitogen-activated protein pathway. Mol Cancer Res 2: 159–169
De Luca A, Mangiacasale R, Severino A, Malquori L, Baldi A, Palena A, Mileo AM, Lavia P, Paggi MG (2003) E1A deregulates the centrosome cycle in a Ran GTPase-dependent manner. Cancer Res 63: 1430–1437
Carbone M, Klein G, Gruber J, Wong M (2004) Modern criteria to establish human cancer etiology. Cancer Res 64: 5518–5524
McDougall JK (2001) “Hit and run” transformation leading to carcinogenesis. Dev Biol (Basel) 106: 77–82
Eigen M (2002) Error catastrophe and antiviral strategy. Proc Natl Acad Sci USA 99: 13374–13376
Vidwans SJ, Wong ML, O’Farrell PH (2003) Anomalous centriole configurations are detected in Drosophila wing disc cells upon Cdk1 inactivation. J Cell Sci 116: 137–143
Duensing S, Lee BH, Dal Cin P, Münger K (2003) Excessive centrosome abnormalities without ongoing numerical chromosome instability in a Burkitt’s lymphoma. Molecular Cancer 2: 30
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Birkhäuser Verlag/Switzerland
About this chapter
Cite this chapter
Münger, K., Hayakawa, H., Nguyen, C.L., Melquiot, N.V., Duensing, A., Duensing, S. (2006). Viral carcinogenesis and genomic instability. In: Cancer: Cell Structures, Carcinogens and Genomic Instability. Experientia Supplementum, vol 96. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7378-4_8
Download citation
DOI: https://doi.org/10.1007/3-7643-7378-4_8
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-7156-2
Online ISBN: 978-3-7643-7378-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)